Money Talks News on MSN2h
Dementia: the Silent Killer Affecting Half of Older Adults
As the prevalence of dementia continues to rise, experts are grappling with the implications of this disease on end-of-life ...
The L.A. fires are contained, but the harm to people’s brains may linger
Researchers say that long-term exposure to high levels of air pollution, particularly wildfire smoke, is linked to dementia.
ScienceAlert2d
This 'Strange' Gas May Hold Promise For Treating Alzheimer's, Study Says
An inert and unreactive gas may not seem like an obvious candidate for treating Alzheimer's disease, yet a new study in mice ...
Deal reached to sell The Harborside retirement community in Port Washington for $80 million
The sale still must be approved by a federal bankruptcy court judge, who has scheduled a hearing for Feb. 12 in Central Islip ...
NBC Washington4d
Man with Alzheimer's disease missing from Waldorf, Maryland
Police are searching for an 86-year-old man with Alzheimer's disease from Waldorf ... He may be in the Fort Washington area. Residents are asked to review their camera footage and contact ...
ConsumerAffairs3d
Exercise may be a key factor in preventing dementia
Scientists at Rutgers University-New Brunswick have published research showing that exercise activates specialized cells in ...
Might xenon gas be useful for treating Alzheimer's, as a new study suggests?
An inert and unreactive gas may not seem like an obvious candidate for treating Alzheimer's disease, yet a new study in mice ...
Phoenix man convicted in Jan. 6 riot in DC allowed back in Washington
A federal judge reversed course and is now allowing Edward Vallejo, a Phoenix man convicted in the Jan. 6 riot, to access ...
Capitals' arena announcer Wes Johnson taken to hospital after medical emergency, team says
Wes Johnson, the longtime arena announcer for the Washington Capitals, was taken to the hospital earlier this month following ...
Opinion: NIH chaos threatened St. Louis' health research excellence
Funding restrictions imposed by the Trump administration threaten not just abstract scientific progress, but the livelihood ...
BioArctic: FDA approves IV maintenance dosing of Leqembi (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US
BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...